Jump to content

Hang onto your hat: Sclero Forums Upgrade May 14-21, 2017!! The Forums will be offline for up to 4 days, and then will return with an entirely new look and feel.

Canadian Health Authority Approves Thelin (Sitaxsentan Sodium) For Pulmonary Arterial Hypertension

  • Please log in to reply
No replies to this topic

#1 Guest_Jude the Grouch_*

Guest_Jude the Grouch_*
  • Guests

Posted 07 June 2007 - 08:07 AM

Canadian Health Authority Approves THELIN (Sitaxsentan Sodium) for Pulmonary Arterial Hypertension. "THELIN has demonstrated a unique benefit for individuals who have developed PAH as a result of a connective tissue disease, such as scleroderma," said Janet Pope, M.D., Professor of Rheumatology, University of Western Ontario and Director, Division of Rheumatology, St. Joseph's Health Centre, London, Ontario. PrimeNewswire. Encysive Pharmaceuticals Inc. 05/30/07. (Also see: Pulmonary Hypertension and ISN: Dr. Janet Pope)